Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-24-000186
Filing Date
2024-12-06
Accepted
2024-12-06 16:34:53
Documents
1
Period of Report
2024-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733520886.html 4  
1 FORM 4 wk-form4_1733520886.xml 4 3616
  Complete submission text file 0001384101-24-000186.txt   5200
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address
Febbo Phillip G. (Reporting) CIK: 0001649245 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 241532811